Technology
Australian biotech, EnGeneIC, develops world-first nanocellular anti-COVID-19 vaccine that defeats mutant viruses and – GlobeNewswire
Works against mutant strains including DeltaNo need for refrigeration during transport and storage No added stabilisers or chemicals…
- Works against mutant strains including Delta
- No need for refrigeration during transport and storage
- No added stabilisers or chemicals
- Safety and immune response clinical trial recruiting now in Melbourne
- Efficacy trial planned for USA
SYDNEY and NEW YORK,…
Continue Reading
-
Business5 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General23 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre
-
General13 hours agoFrench far-right supporters rally against Le Pen conviction in Paris
-
General20 hours agoFire razes Tumby Bay hardware store with damage likely to exceed $1m